Publications by authors named "Tiziana Fernandez"
Article Synopsis
- Tracheostomy can provide crucial benefits for pediatric ICU patients, but it carries risks, particularly accidental decannulation (AD), which can be life-threatening.
- A case-control study was conducted involving 140 tracheostomized children, identifying 41 cases of AD and 82 controls during their hospitalization from 2013-2018.
- Key factors linked to an increased risk of AD included the child's ability to sit up and reach the midline, using a smaller tracheostomy tube (≤ 4.0 mm diameter), and having less nursing supervision in the hospital.
Diaphragm dysfunction is a highly prevalent phenomenon in patients receiving mechanical ventilation, mainly due to ventilatory over-assistance and the development of diaphragm disuse atrophy. Promoting diaphragm activation whenever possible and facilitating an adequate interaction between the patient and the ventilator is encouraged at the bedside to avoid myotrauma and further lung injury. Eccentric contractions of the diaphragm are defined as muscle activation while muscle fibers are lengthening within the exhalation phase.
View Article and Find Full Text PDFBackground: Despite recent initiatives and efforts, gender inequality still exists in medicine and academia. There is a higher proportion of male authors in international scientific publications.
Aim: To compare the proportion of female and male authors in the scientific publications of the main medical journals in Chile.
Non-alcoholic fatty liver disease (NAFLD) represents an excessive fat accumulation within the liver, usually associated with excess body weight. A liver biopsy is the gold standard for diagnosis, but it is inapplicable in population-based studies. In large populations, non-invasive methods could be used, which may also serve to identify potential protective factors.
View Article and Find Full Text PDFBackground: Non-alcoholic fatty liver disease is a liver condition that is increasing worldwide and expected to become the number one cause of cirrhosis and hepatocellular carcinoma in the next 5 years. Currently there are no successful or approved pharmacological treatments. Weight loss is the first-line therapy as a 7 to 10% reduction improves steatosis, inflammation, hepatocyte ballooning, and fibrosis.
View Article and Find Full Text PDF